Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

RBC Capital Maintains Outperform on Wix.com, Raises Price Target to $315

RBC Capital analyst Brad Erickson maintains Wix.com (NASDAQ:WIX) with a Outperform and raises the price target from $300 to $315.

byBenzinga Newsdesk

June 14, 2021

1 minute read

RBC Capital analyst Brad Erickson maintains Wix.com (NASDAQ:WIX) with a Outperform and raises the price target from $300 to $315.

Barclays Initiates Coverage On KKR & Co with Overweight Rating, Announces Price Target of $69

By Benzinga Newsdesk

Today, 6:23 AM

Barclays analyst Benjamin Budish initiates coverage on KKR & Co (NYSE:KKR) with a Overweight rating and announces Price Target of $69.

KKR

Keefe, Bruyette & Woods Upgrades WR Berkley to Outperform, Raises Price Target to $80

By Benzinga Newsdesk

Today, 6:23 AM

Keefe, Bruyette & Woods analyst Meyer Shields upgrades WR Berkley (NYSE:WRB) from Market Perform to Outperform and raises the price target from $77 to $80.

WRB

Bluejay Diagnostics, Inc. Announces its Pre-Submission Filing Package For The Symphony IL-6 Test Is With The FDA

By Bill Haddad

Today, 6:23 AM

Bluejay Diagnostics, Inc. (NASDAQ:BJDX) (“Bluejay”, “the Company”) a late-stage, pre-revenue diagnostics company focused on developing cost-effective, rapid, near-patient products for triage and

BJDX